Prevention, Diagnosis, Therapy, and Follow-up of Lung Cancer: Interdisciplinary Guideline of the German Respiratory Society and the German Cancer Society - Abridged Version

被引：4

作者：

Schuette, Wolfgang ^{[1
]}

Guetz, Sylvia ^{[2
]}

Nehls, Wiebke ^{[3
]}

Blum, Torsten Gerriet ^{[4
]}

Brueckl, Wolfgang ^{[5
]}

Buttmann-Schweiger, Nina ^{[6
]}

Buettner, Reinhard ^{[7
]}

Christopoulos, Petros ^{[8
]}

Delis, Sandra ^{[9
]}

Deppermann, Karl M. ^{[10
]}

Dickgreber, Nikolas ^{[11
]}

Eberhardt, Wilfried ^{[12
]}

Eggeling, Stephan ^{[13
]}

Fleckenstein, Jochen ^{[14
]}

Flentje, Michael ^{[15
]}

Frost, Nikolaj ^{[16
]}

Griesinger, Frank ^{[17
]}

Grohe, Christian ^{[18
]}

Groeschel, Andreas ^{[19
]}

Guckenberger, Matthias ^{[20
]}

Hecker, Erich ^{[21
]}

Hoffmann, Hans ^{[22
]}

Huber, Rudolf M. ^{[23
]}

Junker, Klaus

Kauczor, Hans-Ulrich ^{[25
]}

Kollmeier, Jens ^{[26
]}

Kraywinkel, Klaus ^{[6
,24
]}

Krueger, Marcus ^{[27
]}

Kugler, Christian ^{[28
]}

Moeller, Miriam ^{[29
]}

Nestle, Ursula ^{[30
]}

Passlick, Bernward ^{[31
]}

Pfannschmidt, Joachim ^{[32
]}

Reck, Martin ^{[33
]}

Reinmuth, Niels ^{[34
]}

Ruebe, Christian ^{[35
]}

Scheubel, Robert ^{[36
]}

Schumann, Christian ^{[37
]}

Sebastian, Martin

Serke, Monika ^{[39
]}

Stoelben, Erich ^{[40
]}

Stuschke, Martin ^{[8
,38
]}

Thomas, Michael ^{[41
]}

Tufman, Amanda ^{[42
]}

Vordermark, Dirk ^{[43
]}

Waller, Cornelius ^{[44
]}

Wolf, Juergen ^{[45
]}

Wolf, Martin ^{[46
]}

Wormanns, Dag ^{[47
]}

机构：

[1] Krankenhaus Martha Maria Halle Dolau, Innere Med Klin 2, Halle, Saale, Germany

[2] St Elisabeth Krankenhaus Leipzig, Innere Med Abt 1, Leipzig, Germany

[3] HELIOS Klinikum Emil von Behring, Klin Palliat Med & Geriatrie, Berlin, Germany

[4] Helios Klinikum Emil von Behring, Lungenklin Heckeshorn, Klin Pneumol, Berlin, Germany

[5] Klinikum Nurnberg Nord, Klin Innere Med 3, Schwerpunkt Pneumol, Nurnberg, Germany

[6] Robert Koch Inst, Zentrum Krebsregisterdaten, Berlin, Germany

[7] Uniklin Koln, Inst Allgemeine Pathol Pathol Anat, Berlin, Germany

[8] Univ Klinikum Heidelberg, Thorak Onkolale, Thoraxklin, Heidelberg, Germany

[9] Helios Klinikum Emil Behring, Klin Pneumol, Lungenklin Heckeshorn, Berlin, Germany

[10] Sana Krankenhaus Gerresheim Sana Kliniken Dusseld, Westdeutsch Diabet & Gesundheitszentrum, D-40625 Dusseldorf, Germany

[11] Univ Klinikum Wurzburg, Klin Allgemein Viszeral Gefass & Kinderchirurg, Wurzburg, Germany

[12] Univ Med Essen Ruhrlandklin, Klin Pneumol, Essen, Germany

[13] Vivantes Netzwerk Gesundheit, Berlin, Germany

[14] Univ Klinikum Saarlandes, Klin Strahlentherap & Radioonkol, Homburg, Germany

[15] Univ Klinikum Wurzburg, Klin & Poliklin Dermatol, D-97080 Wurzburg, Germany

[16] Charite Univ Med Berlin, Med Klin Schwerpunkt Infektiol Pneumol, Berlin, Germany

[17] Pius Hosp Oldenburg, Klin Hamatol & Onkol, Oldenburg, Germany

[18] Evangel Lungenklin, Klin Pneumol, Berlin, Germany

[19] Raphaelsklin Munster, Abt Urol, Munster, Germany

[20] Univ Spital Zurich, Klin Radioonkol, Zurich, Switzerland

[21] Thoraxzentrum Ruhrgebiet, Bochum, Germany

[22] Klin & Poliklin TU Munchen, Klinikum Rechts Isar, D-81675 Munich, Germany

[23] LMU Klinikum Munchen, Med Klin und Poliklin 5, Thorakale Onkol, Munich, Germany

[24] Krankenstalt Bremen, Inst Pathol, Bremen, Germany

[25] Klinikum Univ Heidelberg, Abt Diagnost Radiol, Heidelberg, Germany

[26] Helios Klinikum Emil Behring, Klin Pneumol, Lungenklin Heckeshorn, Berlin, Germany

[27] Krankenhaus Martha Maria Halle Dolau, Klin Thoraxchirurg, Halle, Germany

[28] Landeskrankenhaus Hochzirl, Abt Innere Med, Hochzirl, Austria

[29] Krankenhaus Martha Maria Halle Dolau, Klin Thorxchirurg, Halle, Germany

[30] Kliniken Maria Hilf, Klin Strahlentherapie, Monchengladbach, Germany

[31] Univ Klinikum Freiburg, Neurol Klin, Freiburg, Germany

[32] Helios Klinikum Emil Behring, Lungenklin Heckeshorn, Klin Thoraxchirurg, Berlin, Germany

[33] Lungeclin Grosshansdorf, Pneumol Onkol Abt, Grosshansdorf, Germany

[34] Asklepios Lungenklin Gauting, Klin Pneumol, Thorakale Onkol, Gauting, Germany

[35] Univ Klinikum Saarlandes UKS, Klin Augenheilkunde, Homburg Saar, Germany

[36] Fachkliniken Wangen, Klin Thoraxchirurg, Wangen An Der Aare, Switzerland

[37] Klinikum Kempten, Klin Pneumol, Kempten, Germany

[38] Univ Klinikum Frankfurt, Med Klin 3, Frankfurt, Germany

[39] Lungenklin Hemer, Zentrum Pneumol & Thoraxchirurg, Hemer, Germany

[40] Thoraxklin Koln, St Hildegardis Koln, Cologne, Germany

[41] Thoraxklin, Heidelberg, Germany

[42] LMU Klinikum Munchen, Med Klin & Poliklin 5, Thorakale Onkol, Munich, Germany

[43] Univ Klinikum Halle, Univ Klin & Poliklin Strahlentherap, Halle, Germany

[44] Univ Klinikum Freiburg, Klin Innere Med 1, Freiburg, Germany

[45] Uniklin Koln, Innere Med 1, Cologne, Germany

[46] Klinikum Kassel, Klin Onkol & Hamatol, Kassel, Germany

[47] Evangel Lungenklin, Radiol Inst, Berlin, Germany

来源：

PNEUMOLOGIE | 2023年 / 77卷 / 10期

关键词：

PHASE-III TRIAL; PROPHYLACTIC CRANIAL IRRADIATION; QUALITY-OF-LIFE; SMALL-CELL-CARCINOMA; STEREOTACTIC BODY RADIOTHERAPY; INDIVIDUAL PATIENT DATA; POSTOPERATIVE ADJUVANT CHEMOTHERAPY; RESECTED STAGE-I; DAILY THORACIC RADIOTHERAPY; RANDOMIZED CONTROLLED-TRIAL;

D O I：

10.1055/a-2029-0134

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

The current S3 Lung Cancer Guidelines are edited with fundamental changes to the previous edition based on the dynamic influx of information to this field:The recommendations include de novo a mandatory case presentation for all patients with lung cancer in a multidisciplinary tumor board before initiation of treatment, furthermore CT-Screening for asymptomatic patients at risk (after federal approval), recommendations for incidental lung nodule management , molecular testing of all NSCLC independent of subtypes, EGFR-mutations in resectable early stage lung cancer in relapsed or recurrent disease, adjuvant TKI-therapy in the presence of common EGFR-mutations, adjuvant consolidation treatment with checkpoint inhibitors in resected lung cancer with PD-L1 >= 50%, obligatory evaluation of PD-L1-status, consolidation treatment with checkpoint inhibition after radiochemotherapy in patients with PD-L1-pos. tumor, adjuvant consolidation treatment with checkpoint inhibition in patients withPD-L1 >= 50% stage IIIA and treatment options in PD-L1 >= 50% tumors independent of PD-L1status and targeted therapy and treatment option immune chemotherapy in first line SCLC patients.Based on the current dynamic status of information in this field and the turnaround time required to implement new options, a transformation to a ,,living guideline" was proposed.

引用

页码：671 / 813

页数：143

共 629 条

[1] Results of the Two Incidence Screenings in the National Lung Screening Trial [J].

Aberle, Denise R. ;

DeMello, Sarah ;

Berg, Christine D. ;

Black, William C. ;

Brewer, Brenda ;

Church, Timothy R. ;

Clingan, Kathy L. ;

Duan, Fenghai ;

Fagerstrom, Richard M. ;

Gareen, Ilana F. ;

Gatsonis, Constantine A. ;

Gierada, David S. ;

Jain, Amanda ;

Jones, Gordon C. ;

Mahon, Irene ;

Marcus, Pamela M. ;

Rathmell, Joshua M. ;

Sicks, JoRean .

NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (10) :920-931

[2] Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening [J].

Aberle, Denise R. ;

Adams, Amanda M. ;

Berg, Christine D. ;

Black, William C. ;

Clapp, Jonathan D. ;

Fagerstrom, Richard M. ;

Gareen, Ilana F. ;

Gatsonis, Constantine ;

Marcus, Pamela M. ;

Sicks, JoRean D. .

NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (05) :395-409

[3] Multinational Randomized Phase III Trial With or Without Consolidation Chemotherapy Using Docetaxel and Cisplatin After Concurrent Chemoradiation in Inoperable Stage III Non-Small-Cell Lung Cancer: KCSG-LU05-04 [J].

Ahn, Jin Seok ;

Ahn, Yong Chan ;

Kim, Joo-Hang ;

Lee, Chang Geol ;

Cho, Eun Kyung ;

Lee, Kyu Chan ;

Chen, Ming ;

Kim, Dong-Wan ;

Kim, Hoon-Kyo ;

Min, Young Joo ;

Kang, Jin-Hyoung ;

Choi, Jin-Hyuck ;

Kim, Sang-We ;

Zhu, Guangying ;

Wu, Yi-Long ;

Kim, Sung Rok ;

Lee, Kyung Hee ;

Song, Hong Suk ;

Choi, Yoon-La ;

Sun, Jong-Mu ;

Jung, Sin-Ho ;

Ahn, Myung-Ju ;

Park, Keunchil .

JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (24) :2660-U124

[4] Compliance with post-operative adjuvant chemotherapy in non-small cell lung cancer - An analysis of National Cancer Institute of Canada and intergroup trial JBR. 10 and a review of the literature [J].

Alam, N ;

Shepherd, FA ;

Winton, T ;

Graham, B ;

Johnson, D ;

Livingston, R ;

Rigas, J ;

Whitehead, M ;

Ding, K ;

Seymour, L .

LUNG CANCER, 2005, 47 (03) :385-394

[5] Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial [J].

Albain, Kathy S. ;

Swann, R. Suzanne ;

Rusch, Valerie W. ;

Turrisi, Andrew T., III ;

Shepherd, Frances A. ;

Smith, Colum ;

Chen, Yuhchyau ;

Livingston, Robert B. ;

Feins, Richard H. ;

Gandara, David R. ;

Fry, Willard A. ;

Darling, Gail ;

Johnson, David H. ;

Green, Mark R. ;

Miller, Robert C. ;

Ley, Joanne ;

Sause, Willliam T. ;

Cox, James D. .

LANCET, 2009, 374 (9687) :379-386

[6] DETERMINANTS OF IMPROVED OUTCOME IN SMALL-CELL LUNG-CANCER - AN ANALYSIS OF THE 2,580-PATIENT SOUTHWEST ONCOLOGY GROUP DATA-BASE [J].

ALBAIN, KS ;

CROWLEY, JJ ;

LEBLANC, M ;

LIVINGSTON, RB .

JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (09) :1563-1574

[7]

ALBERTUCCI M, 1992, J THORAC CARDIOV SUR, V103, P8

[8] Computed Tomography Bronchus Sign and the Diagnostic Yield of Guided Bronchoscopy for Peripheral Pulmonary Lesions A Systematic Review and Meta-Analysis [J].

Ali, Muhammad S. ;

Sethi, Jaskaran ;

Taneja, Amit ;

Musani, Ali ;

Maldonado, Fabien .

ANNALS OF THE AMERICAN THORACIC SOCIETY, 2018, 15 (08) :978-987

[9] Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer: Initial results of the randomized, prospective ACOSOG Z0030 trial [J].

Allen, MS ;

Darling, GE ;

Pechet, TTV ;

Mitchell, JD ;

Herndon, JE ;

Landreneau, RJ ;

Inculet, RI ;

Jones, DR ;

Meyers, BF ;

Harpole, DH ;

Putnam, JB ;

Rusch, VW .

ANNALS OF THORACIC SURGERY, 2006, 81 (03) :1013-1019

[10] Survival of patients with resected N2 non-small-cell lung cancer: Evidence for a subclassification and implications [J].

Andre, F ;

Grunenwald, D ;

Pignon, JP ;

Dujon, A ;

Pujol, JL ;

Brichon, PY ;

Brouchet, L ;

Quoix, E ;

Westeel, V ;

Le Chevalier, T .

JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (16) :2981-2989

← 1 2 3 4 5 6 7 8 9 10 →